Stock info Neogenomics Inc | Filter  Basic-Info

Neogenomics Inc

The past year was a profitable year for Neogenomics Inc investors

Over the period from December 2015 till December 2016 the stock gained around 15 percent. Over the period from December 2011 till December 2016 the stock rose on average 569 percent. Neogenomics Inc's revenues between 2011 and 2015 were far from constant and moved between 59,87 million dollars and 99,8 million dollars. Neogenomics Inc's net results between 2011 and 2015 were far from constant and moved between -1,18 million dollars and -2,54 million dollars.

Neogenomics Inc is mostly active in the software sector. The global software & services companies gained over the past 10 years on average 70 percent. Measured since 2011 the sector is 68 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 70 percent.

Over the past 5 years the American company paid out dividends.

Neogenomics Inc' balance mostly financed with equity

At the end of 2015 the software & services company's balance sheet equaled 367,96 million dollars. At the end of 2015 the total debt positon equaled 129,85 million dollars. This is around 35,29 percent of the total balance sheet. As per the end of 2015 Neogenomics Inc's price/earnings-ratio equaled -104. So investors paid for 1 stock -104 times the earnings per share of 2015. Based on the classical stock valuation theories the American stock can be seen as a growth stock.

At the end of 2015 the software & services company's market size (her number of outstanding share times the stock price) equaled around 460,6 million dollars. At the end of 2015 the American company had around 60,53 million stocks listed.

All Neogenomics Inc's annual reports can be found here. More information about Neogenomics Inc can be found it's website. .